CN107242576A - The pregnant woman and wet nurse of a kind of instant are with nutritious supplementary pharmaceutical product and preparation method thereof - Google Patents
The pregnant woman and wet nurse of a kind of instant are with nutritious supplementary pharmaceutical product and preparation method thereof Download PDFInfo
- Publication number
- CN107242576A CN107242576A CN201710437705.3A CN201710437705A CN107242576A CN 107242576 A CN107242576 A CN 107242576A CN 201710437705 A CN201710437705 A CN 201710437705A CN 107242576 A CN107242576 A CN 107242576A
- Authority
- CN
- China
- Prior art keywords
- nutrient
- pregnant woman
- nutritious supplementary
- supplementary pharmaceutical
- container
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000008935 nutritious Nutrition 0.000 title claims abstract description 72
- 239000000825 pharmaceutical preparation Substances 0.000 title claims abstract description 15
- 229940127557 pharmaceutical product Drugs 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 235000015097 nutrients Nutrition 0.000 claims abstract description 66
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 63
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 63
- 239000000463 material Substances 0.000 claims abstract description 42
- 239000011261 inert gas Substances 0.000 claims abstract description 26
- 239000000047 product Substances 0.000 claims abstract description 25
- 238000004519 manufacturing process Methods 0.000 claims abstract description 19
- 238000007789 sealing Methods 0.000 claims abstract description 18
- 239000004615 ingredient Substances 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims description 86
- 235000018102 proteins Nutrition 0.000 claims description 62
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 53
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 42
- 235000010469 Glycine max Nutrition 0.000 claims description 32
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 30
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 30
- 239000002245 particle Substances 0.000 claims description 29
- 239000000706 filtrate Substances 0.000 claims description 28
- 238000010438 heat treatment Methods 0.000 claims description 27
- 239000002994 raw material Substances 0.000 claims description 27
- 235000016709 nutrition Nutrition 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 23
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 21
- 239000001569 carbon dioxide Substances 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 21
- 231100000252 nontoxic Toxicity 0.000 claims description 21
- 230000003000 nontoxic effect Effects 0.000 claims description 21
- CAXNYFPECZCGFK-UHFFFAOYSA-N 2-phenyl-2-pyridin-2-ylacetonitrile Chemical compound C=1C=CC=NC=1C(C#N)C1=CC=CC=C1 CAXNYFPECZCGFK-UHFFFAOYSA-N 0.000 claims description 20
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 claims description 20
- 238000002161 passivation Methods 0.000 claims description 20
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 18
- 244000068988 Glycine max Species 0.000 claims description 18
- 239000011575 calcium Substances 0.000 claims description 18
- 229910052791 calcium Inorganic materials 0.000 claims description 18
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 16
- 238000009835 boiling Methods 0.000 claims description 16
- 229910052742 iron Inorganic materials 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 14
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 14
- 239000011777 magnesium Substances 0.000 claims description 14
- 229910052749 magnesium Inorganic materials 0.000 claims description 14
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 13
- 239000011669 selenium Substances 0.000 claims description 13
- 239000011701 zinc Substances 0.000 claims description 13
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- 239000004743 Polypropylene Substances 0.000 claims description 12
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 12
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 12
- 239000007791 liquid phase Substances 0.000 claims description 12
- 238000000926 separation method Methods 0.000 claims description 12
- 229910052725 zinc Inorganic materials 0.000 claims description 12
- -1 polypropylene Polymers 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 11
- 108090000790 Enzymes Proteins 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 10
- 239000004698 Polyethylene Substances 0.000 claims description 10
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 9
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 9
- 239000000796 flavoring agent Substances 0.000 claims description 9
- 235000019634 flavors Nutrition 0.000 claims description 9
- 229920000573 polyethylene Polymers 0.000 claims description 9
- 238000001556 precipitation Methods 0.000 claims description 9
- 229910052711 selenium Inorganic materials 0.000 claims description 9
- 239000007921 spray Substances 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 claims description 8
- 102000003820 Lipoxygenases Human genes 0.000 claims description 8
- 108090000128 Lipoxygenases Proteins 0.000 claims description 8
- 108010073771 Soybean Proteins Proteins 0.000 claims description 8
- 239000000470 constituent Substances 0.000 claims description 8
- 235000012054 meals Nutrition 0.000 claims description 8
- 235000019161 pantothenic acid Nutrition 0.000 claims description 8
- 239000011713 pantothenic acid Substances 0.000 claims description 8
- 229940055726 pantothenic acid Drugs 0.000 claims description 8
- 238000012545 processing Methods 0.000 claims description 8
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 8
- 235000019710 soybean protein Nutrition 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 7
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 7
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 7
- 229960002685 biotin Drugs 0.000 claims description 7
- 235000020958 biotin Nutrition 0.000 claims description 7
- 239000011616 biotin Substances 0.000 claims description 7
- 229960003512 nicotinic acid Drugs 0.000 claims description 7
- 235000019155 vitamin A Nutrition 0.000 claims description 7
- 239000011719 vitamin A Substances 0.000 claims description 7
- 235000019154 vitamin C Nutrition 0.000 claims description 7
- 239000011718 vitamin C Substances 0.000 claims description 7
- 229940045997 vitamin a Drugs 0.000 claims description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 6
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 6
- 229930003779 Vitamin B12 Natural products 0.000 claims description 6
- 229930003268 Vitamin C Natural products 0.000 claims description 6
- 230000004888 barrier function Effects 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 229960000304 folic acid Drugs 0.000 claims description 6
- 235000019152 folic acid Nutrition 0.000 claims description 6
- 239000011724 folic acid Substances 0.000 claims description 6
- 235000001968 nicotinic acid Nutrition 0.000 claims description 6
- 239000011664 nicotinic acid Substances 0.000 claims description 6
- 229920001155 polypropylene Polymers 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 235000019163 vitamin B12 Nutrition 0.000 claims description 6
- 239000011715 vitamin B12 Substances 0.000 claims description 6
- 229930003451 Vitamin B1 Natural products 0.000 claims description 5
- 229930003316 Vitamin D Natural products 0.000 claims description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 5
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 5
- 229960001231 choline Drugs 0.000 claims description 5
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 5
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 5
- 239000004715 ethylene vinyl alcohol Substances 0.000 claims description 5
- 235000019197 fats Nutrition 0.000 claims description 5
- 235000013312 flour Nutrition 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 229960003495 thiamine Drugs 0.000 claims description 5
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 5
- 235000010374 vitamin B1 Nutrition 0.000 claims description 5
- 239000011691 vitamin B1 Substances 0.000 claims description 5
- 235000019166 vitamin D Nutrition 0.000 claims description 5
- 239000011710 vitamin D Substances 0.000 claims description 5
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 5
- 229940046008 vitamin d Drugs 0.000 claims description 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 4
- 229920001328 Polyvinylidene chloride Polymers 0.000 claims description 4
- 229930003448 Vitamin K Natural products 0.000 claims description 4
- 239000008393 encapsulating agent Substances 0.000 claims description 4
- UFRKOOWSQGXVKV-UHFFFAOYSA-N ethene;ethenol Chemical compound C=C.OC=C UFRKOOWSQGXVKV-UHFFFAOYSA-N 0.000 claims description 4
- 238000001704 evaporation Methods 0.000 claims description 4
- 230000008020 evaporation Effects 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 4
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 4
- 239000005033 polyvinylidene chloride Substances 0.000 claims description 4
- 235000004252 protein component Nutrition 0.000 claims description 4
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 4
- 235000019158 vitamin B6 Nutrition 0.000 claims description 4
- 239000011726 vitamin B6 Substances 0.000 claims description 4
- 235000019168 vitamin K Nutrition 0.000 claims description 4
- 239000011712 vitamin K Substances 0.000 claims description 4
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 4
- 229940011671 vitamin b6 Drugs 0.000 claims description 4
- 229940046010 vitamin k Drugs 0.000 claims description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 229930003471 Vitamin B2 Natural products 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- 229920006248 expandable polystyrene Polymers 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 229960003966 nicotinamide Drugs 0.000 claims description 3
- 235000005152 nicotinamide Nutrition 0.000 claims description 3
- 239000011570 nicotinamide Substances 0.000 claims description 3
- 230000000050 nutritive effect Effects 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 229960002477 riboflavin Drugs 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 235000019164 vitamin B2 Nutrition 0.000 claims description 3
- 239000011716 vitamin B2 Substances 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 210000000481 breast Anatomy 0.000 claims description 2
- 230000003647 oxidation Effects 0.000 claims description 2
- 101000576320 Homo sapiens Max-binding protein MNT Proteins 0.000 claims 1
- 239000004677 Nylon Substances 0.000 claims 1
- 229920006121 Polyxylylene adipamide Polymers 0.000 claims 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 1
- 239000000835 fiber Substances 0.000 claims 1
- 229920001778 nylon Polymers 0.000 claims 1
- 210000004885 white matter Anatomy 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 abstract description 3
- 210000003754 fetus Anatomy 0.000 description 31
- 235000013305 food Nutrition 0.000 description 27
- 230000035935 pregnancy Effects 0.000 description 21
- 239000002775 capsule Substances 0.000 description 20
- 230000000694 effects Effects 0.000 description 16
- 238000011161 development Methods 0.000 description 15
- 230000018109 developmental process Effects 0.000 description 15
- 230000035764 nutrition Effects 0.000 description 13
- 208000007502 anemia Diseases 0.000 description 12
- 239000013589 supplement Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 150000001413 amino acids Chemical class 0.000 description 9
- 238000007908 dry granulation Methods 0.000 description 9
- 229940088598 enzyme Drugs 0.000 description 9
- 230000001605 fetal effect Effects 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 230000002950 deficient Effects 0.000 description 8
- 235000013336 milk Nutrition 0.000 description 8
- 239000008267 milk Substances 0.000 description 8
- 210000004080 milk Anatomy 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 229940088594 vitamin Drugs 0.000 description 8
- 229930003231 vitamin Natural products 0.000 description 8
- 235000013343 vitamin Nutrition 0.000 description 8
- 239000011782 vitamin Substances 0.000 description 8
- 150000003722 vitamin derivatives Chemical class 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- 235000014347 soups Nutrition 0.000 description 7
- 229910052782 aluminium Inorganic materials 0.000 description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 230000009469 supplementation Effects 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 239000004411 aluminium Substances 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 229920002799 BoPET Polymers 0.000 description 4
- 208000032170 Congenital Abnormalities Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 244000046052 Phaseolus vulgaris Species 0.000 description 4
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 108010046334 Urease Proteins 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000004641 brain development Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000013601 eggs Nutrition 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 206010000234 Abortion spontaneous Diseases 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- 206010027336 Menstruation delayed Diseases 0.000 description 3
- 229920000007 Nylon MXD6 Polymers 0.000 description 3
- 206010033546 Pallor Diseases 0.000 description 3
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 3
- 206010036600 Premature labour Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 208000007287 cheilitis Diseases 0.000 description 3
- 230000035606 childbirth Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000001161 mammalian embryo Anatomy 0.000 description 3
- 239000011785 micronutrient Substances 0.000 description 3
- 235000013369 micronutrients Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 208000015994 miscarriage Diseases 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 208000026440 premature labor Diseases 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 208000000995 spontaneous abortion Diseases 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 2
- 206010006956 Calcium deficiency Diseases 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 230000004543 DNA replication Effects 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 208000005232 Glossitis Diseases 0.000 description 2
- 206010053759 Growth retardation Diseases 0.000 description 2
- 101710154606 Hemagglutinin Proteins 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 2
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 2
- 208000027530 Meniere disease Diseases 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 2
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 101710176177 Protein A56 Proteins 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 206010048259 Zinc deficiency Diseases 0.000 description 2
- 206010000210 abortion Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 238000005842 biochemical reaction Methods 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 235000019621 digestibility Nutrition 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 231100000001 growth retardation Toxicity 0.000 description 2
- 239000000185 hemagglutinin Substances 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 210000001320 hippocampus Anatomy 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 208000018773 low birth weight Diseases 0.000 description 2
- 231100000533 low birth weight Toxicity 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 230000007472 neurodevelopment Effects 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 238000013021 overheating Methods 0.000 description 2
- 239000005022 packaging material Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 235000002949 phytic acid Nutrition 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 108010048090 soybean lectin Proteins 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 208000002254 stillbirth Diseases 0.000 description 2
- 231100000537 stillbirth Toxicity 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 1
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010005176 Blindness congenital Diseases 0.000 description 1
- 206010070817 Bone decalcification Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 208000009849 Female Genital Neoplasms Diseases 0.000 description 1
- 208000006893 Fetal Hypoxia Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 206010016880 Folate deficiency Diseases 0.000 description 1
- 208000010188 Folic Acid Deficiency Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018092 Generalised oedema Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 101710094902 Legumin Proteins 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 208000035752 Live birth Diseases 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000005736 Nervous System Malformations Diseases 0.000 description 1
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000002141 Pellagra Diseases 0.000 description 1
- 208000001300 Perinatal Death Diseases 0.000 description 1
- 108010047620 Phytohemagglutinins Proteins 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000002787 Pregnancy Complications Diseases 0.000 description 1
- 241000533293 Sesbania emerus Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 208000003217 Tetany Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010072665 Tooth demineralisation Diseases 0.000 description 1
- 208000010011 Vitamin A Deficiency Diseases 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 201000000839 Vitamin K Deficiency Bleeding Diseases 0.000 description 1
- 206010047634 Vitamin K deficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- FRYDSOYOHWGSMD-UHFFFAOYSA-N [C].O Chemical compound [C].O FRYDSOYOHWGSMD-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 208000024783 anasarca Diseases 0.000 description 1
- 201000003465 angular cheilitis Diseases 0.000 description 1
- 230000002460 anti-migrenic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003167 anti-vitamin Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 238000001479 atomic absorption spectroscopy Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000018678 bone mineralization Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- NEKNNCABDXGBEN-UHFFFAOYSA-L disodium;4-(4-chloro-2-methylphenoxy)butanoate;4-(2,4-dichlorophenoxy)butanoate Chemical compound [Na+].[Na+].CC1=CC(Cl)=CC=C1OCCCC([O-])=O.[O-]C(=O)CCCOC1=CC=C(Cl)C=C1Cl NEKNNCABDXGBEN-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 230000004578 fetal growth Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- 235000021125 infant nutrition Nutrition 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 230000021332 multicellular organism growth Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000004179 neuropil Anatomy 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000006286 nutrient intake Nutrition 0.000 description 1
- 210000003300 oropharynx Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 235000021485 packed food Nutrition 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000001885 phytohemagglutinin Effects 0.000 description 1
- 230000028742 placenta development Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 208000012113 pregnancy disease Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000033504 synapse organization Effects 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 208000016794 vitamin K deficiency hemorrhagic disease Diseases 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/18—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient
- B65D81/20—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas
- B65D81/2069—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas in a special atmosphere
- B65D81/2076—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas in a special atmosphere in an at least partially rigid container
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D85/00—Containers, packaging elements or packages, specially adapted for particular articles or materials
- B65D85/70—Containers, packaging elements or packages, specially adapted for particular articles or materials for materials not otherwise provided for
- B65D85/804—Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package
- B65D85/816—Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package into which liquid is added and the resulting preparation is retained, e.g. cups preloaded with powder or dehydrated food
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mechanical Engineering (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Marine Sciences & Fisheries (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Nutritious supplementary pharmaceutical product is used the invention discloses a kind of pregnant woman of instant and wet nurse, it is characterised in that the container being made up of nutritious supplementary pharmaceutical and exotic material is constituted;The nutritious supplementary pharmaceutical is put into exotic material container, sealing container, and inert gas is filled with container;The nutritional supplement ingredients weight ratio is:18~35 parts of good protein, 1 10 parts of nutrient, 50 84 parts of auxiliary material, the product instant, safe ready absorbs more preferable, preparation method is simple, is adapted to industrialized production.
Description
Technical field
The present invention relates to field of health care products, the more particularly to pregnant woman of instant and wet nurse's nutritious supplementary pharmaceutical.
Background technology
Existing pregnant woman and wet nurse milk powder is pregnant woman, the measure of women breast-feeding their children's improvement nutrition condition on the market, is used as meals
Diversified part or extra supplement are eaten, target group's pregnancy period, nursing period is met to the additional demand of nutrient.Pregnant woman
And wet nurse's milk powder belongs to modulation milk powder, GB19644 should be met《National food safety standard milk powder》Requirement, enterprise can basis
GB14880《National food safety standard food enrichment uses standard》Requirement, voluntarily strengthen some battalion in the product
Support element.The label of such product should meet GB7718《National food safety standard prepackaged food label general rule》And GB28050
《National food safety standard prepackaged food nutritional labeling general rule》Requirement.
The present invention relates to a kind of safe, instant pregnant woman and wet nurse's nutritional supplementation agent capsules and its corresponding preparation
Method, is a kind of food for the purpose of supplementing protein and micronutrient, is a kind of highdensity nutrient supplement food, production
Micronutrient content requirement is significantly higher than pregnant woman and the wet nurse's milk powder of reinforcing in product.The based food belongs to food for special foods
Classification, can be that nutrient content is basis in pregnant woman and wet nurse's supplement good protein and lot of trace nutrient, its product
《DRIs 2013》, the diet nutrient intake data of combining target crowd etc. determine
's.The technical indicator of such product should meet GB 31601《National food safety standard-pregnant woman and wet nurse's nutrient supplement food》
Requirement, its label should meet GB13432《National food safety standard-pre-packaged food for special foods label》Requirement.
Safety, instant pregnant woman and wet nurse's nutritional supplementation agent capsules provide a kind of protein and other needs for target group
The compensation process of nutrient, can ensure pregnant woman and wet nurse as pregnant woman and conveniently, safely one of method of wet nurse's nutrition improvement
Nutritional need and edible safety, it will played a role to the nutrition improvement of China pregnant woman and wet nurse.
The content of the invention
It is an object of the invention to provide a kind of good protein and lot of trace existed for China pregnant woman and wet nurse
The nutrition correlative problems such as Nutrition intake deficiency and the food for special foods of a kind of instant produced and processed, addition
Good protein and lot of trace nutrient (vitamin and mineral etc.), to meet pregnant women itself and cyotrophy
Specific demand, meets the specific demand of postpartum women itself and infant nutrition, to pregnant woman and wet nurse's good protein and various
The supplement of micronutrient will play very important effect, promote fetus or baby's normal development, prevention and reduction pregnancy period are simultaneously
The generation for the problems such as sending out disease and low birth weight infant.Contribute to wet nurse's postpartum physical recovery and galactosis, promote neonate to be good for
Kang Fayu.Another object of the present invention is to provide the pregnant woman of instant and the preparation method of wet nurse's nutritious supplementary pharmaceutical.
To achieve the above object, the present invention is achieved through the following technical solutions:
The pregnant woman and wet nurse of a kind of instant of the present invention use nutritious supplementary pharmaceutical product, it is characterised in that be by nutrition
The container of replenishers and exotic material composition is constituted;The nutritious supplementary pharmaceutical is put into exotic material container, sealing container,
Inert gas is filled with container;The nutritious supplementary pharmaceutical includes following weight parts composition:
Good protein
1-10 parts of nutrient,
35-84 parts of auxiliary material.
Further preferably, nutritious supplementary pharmaceutical of the present invention includes following weight percent composition:
25-30 parts of good protein,
2-5 parts of nutrient,
50-69 parts of auxiliary material.
In good protein of the present invention without fishy smell, ANFs should not be contained.
Good protein of the present invention should be in soyabean protein powder, soybean protein powder product, newborn class, dairy products
One or more, preferred soyabean protein powder.
Nutrient of the present invention includes core nutrient (must have) and selective nutrient.Described core nutrition
The composition of element see the table below 1:
The core nutrient of table 1
Core nutrient | Pregnant woman uses (daily μ g) | Wet nurse uses (daily μ g) |
Vitamin A | 230-700 | 400-1200 |
Vitamin D | 3-10 | 3-10 |
Vitamin B12 | 1.2-4.8 | 1.3-5.2 |
Folic acid | 140-400 | 130-400 |
Iron | 9000-18000 | 7000-16000 |
The selective nutrient includes one or more of table 2.
The selective nutrient of table 2
Further preferably, the core nutrient preferred weight ratio is shown in Table 3:
The core nutrient preferred weight ratio of table 3
Core nutrient | Pregnant woman uses (daily μ g) | Wet nurse uses (daily μ g) |
Vitamin A | 400-600 | 800-1000 |
Vitamin D | 6-8 | 8-10 |
Vitamin B12 | 3.6-4.0 | 4.0-5.0 |
Folic acid | 300-400 | 300-400 |
Iron | 15000-16000 | 14000-15000 |
Further preferably, the selective nutrient preferred weight ratio is shown in Table 4
The selective nutrient preferred weight ratio of table 4:
Selective nutrient | Pregnant woman (daily μ g) | Wet nurse (daily μ g) |
Vitamin E (а-TE) | 10000-12000 | 12000-15000 |
Vitamin K | 50-70 | 60-80 |
Vitamin B1 | 2000-2500 | 2500-2800 |
Vitamin B2 | 2000-2400 | 2000-2800 |
Vitamin B6 | 3800-4200 | 2800-3000 |
Vitamin C | 180-200 | 200-260 |
Nicotinic acid (niacinamide) | 12000-15000 | 12000-16000 |
Pantothenic acid | 8000-10000 | 10000-12000 |
Choline | 600000-800000 | 800000-1000000 |
Biotin | 50-70 | 60-80 |
Docosahexaenoic acid | 120000-160000 | 120000-180000 |
Calcium | 400000-600000 | 500000-800000 |
Magnesium | 250000-300000 | 250000-300000 |
Zinc | 5000-8000 | 7000-10000 |
Selenium | 30-45 | 45-60 |
Soyabean protein powder fishy smell of the present invention is the fat oxidation oxydasis multivalence unsaturated lipid in soyabean protein powder
The low molecular weight volatile induced gas such as a class alcohol, aldehyde, ketone and the acid that fat acid (mainly including linoleic acid, leukotrienes etc.) is generated afterwards,
And these micromolecular compounds are most of all with different degrees of peculiar smell, that is, form the different fishy smell of soybean.Soybean protein
Powder fishy smell directly limit the edible extensively of soyabean protein powder.Pregnant woman and wet nurse are more difficult to receive soyabean protein powder fishy smell, directly
Connect and limit the edible of pregnant woman and wet nurse.
ANFs of the present invention refers to that digestion, absorption and utilization to nutriment have a negative impact and made
The material that humans and animals produce adverse reaction includes pancreas egg enzyme inhibitor, plant hemagglutinin
(Phytohemagglutinin, PHA), soybean agglutinin, antigen protein, tannin, saponin(e, phytate phosphorus, soy oligosaccharide, different Huang
Ketone, the antivitamin factor --- it is one or more of in lipoxidase (abbreviation Lox), urase.
The pancreas egg enzyme inhibition factor can reduce pancreas chymotrypsin activity, growth retardation, pancreatic regeneration enlargement.It is described to plant
Thing hemagglutinin includes soybean agglutinin, can damage intestinal wall, immune response, increases endogenous nitrogen output, increases endogenous
Albumen endocrine.The antigen protein immune response influences intestinal wall integrality.The tannin is by forming protein carbon hydrate
Thing compound, the digestion of influence protein and carbohydrate.Saponin(e can haemolysis, and influence gut permeability.Phytate phosphorus and egg
White matter and trace element form compound, the digestion of influence protein and carbohydrate.Described soy oligosaccharide can flatulence, abdomen
Rush down, influence Nutrients Digestion.The isoflavones can suppress production, and increase uterus.The antimicrobial agent can be to micro- life
The utilization of thing, causes vitamin-deficiency.
In above-mentioned nutritious supplementary pharmaceutical, various nutrients and its addition are also by screening.
The vitamin A:The increase and reserve supply that the development of fetus body growth and parent are respectively organized in the gestational period are equal
Need substantial amounts of vitamin A.Zooscopy is found:Gestational period vitamin A deficiency, can cause miscarriage, dysontogenesis, childhood
Growth of animal is stagnated and bone, tooth form bad.During vitamin A wretched insufficiency, animal skeleton and other malformations can be caused.But
The vitamin A of excess intake, it is also possible to cause the normal development of fetal anomaly and influence fetus.
Vitamin D:Pregnant woman be deficient in vitamin D lack not only influence itself be pregnant and production process in health status,
May influence fetus and it is neonatal grow and bone calcification, and long-range influence is produced on the health after adult.
Folic acid:Folic acid is a kind of water-soluble B vitamin, and pregnant woman is higher than normal person to the demand of folic acid 4 times, pregnant early stage
It is the differentiation of Foetal organ's system, the critical period of placentation, cell growth divides very vigorous.Now folic acid deficiency can be led
Cause fetal anomaly.
Vitamin B12:Woman gestationperiod digestion and absorption function strengthens, it is necessary to increase be measured, if pregnant woman is deficient in vitamin
B12, can occur trophism maxicell anaemia, and neonate can also suffer from anaemia.So, vitamin B12 is particularly significant to pregnant woman.
Iron:Iron is one of primary raw material of human body generation red blood cell, and metabolism is accelerated after pregnancy, the increase of iron requirement,
The hypoferric anemia in pregnancy period, can not only cause pregnant woman palpitation and short breath occur, dizziness, weak, can also result in intrauterine fetal anoxia,
Growth retardation, intelligence development obstacle after life is susceptible to suffer from nutritional iron deficiency anemia etc. after life within 6 months.Pregnant woman will be certainly
Oneself and fetus are in utero and sufficient Blood lipids are carried out in the hematopoiesis in postpartum, therefore, in the pregnancy period it should be specifically noted that supplement chalybeate.Pregnancy period
Increase in demand to various nutrition, especially iron.In addition to maintaining the need for itself, also iron is provided for fetal growth, be used to
The need for supply fetal blood and histocyte are growing, and there is a great deal of be stored in fetus liver.If pregnant woman sends out
Raw hypoferric anemia, not only easily occurs various complication, the influence to fetus is bigger, for example, cause fetal in utero in childbirth
Hypoevolutism, low birth weight, premature labor, stillbirth, neonatal death etc..In addition, also affecting the development of fetus immune system.
Therefore, the iron of pregnancy period supplement doses is necessary.
Vitamin E (or а-tocopherol):Pregnant woman is deficient in vitamin if E and is easy to cause fetal irritability, post-abortion to be difficult
Become pregnant again, or cause the symptoms such as skin early ageing, trichomadesis.
Vitamin K:The K if gestational period is deficient in vitamin, its abortion ratio increase, even if survival, due to its internal fibrin ferment
Lowly, easy bleeding, or cause fetal congenital blindness and MR and stillborn foetus.Therefore, pregnant woman should be noted that richness of ingesting
Food containing vitamin K, to prevent postpartum neonate to cause encephalic, hemorrhage of digestive tract etc. because of vitamin K deficiency.
Vitamin B1:Vitamin B1 is water solubility, and in human body in addition to intestinal bacterium can synthesize a part, human body itself is not
Energy synthetic vitamin B1, is mainly derived from food.The B1 pregnant woman of being deficient in vitamin can make neonate cease congenital athlete's foot, birth
When anasarca, body temperature is low, sucks powerless, often vomiting, and limb adynamia, lethargic sleep all day or sob are faint, the morbid night crying of babies.
Vitamin B2:The B2 if ready-to-be mother is deficient in vitamin at pregnant initial stage, can be by influenceing the metabolism of nicotinic acid, and then influences
The development of fetal central nervous system, causes nervous system malformation.Protein metabolism and development of fetus can be also influenceed simultaneously, fetus can be made
Subchondral drilling is obstructed, and occurs skeleton deformity, and such as long bone shortens, rib-fusions symptom.If to be deficient in vitamin in pregnant latter stage
B2, can cause angular stomatitis, glossitis, cheilitis, can increase premature's incidence, and premature infant and stillbirth youngster increase.
Vitamin B6:Caused vomiting of the vitamin B6 to a variety of causes, the especially vomiting of pregnancy have controls curative effect well
Really, because it participates in women vivo protein, the metabolism of fat, carbohydrate and some hormones, pregnant woman needs to take VB6
When, it must take in right amount.So both to own beneficial, there is favourable to fetus.
Nicotinic acid (or niacinamide):Nicotinic acid is exactly vitamin B3, or nicotinic acid, if during its shortage, can produce pellagra, table
It is now the symptoms such as dermatitis, glossitis, oropharynx, diarrhoea and agitation, insomnia cacesthesia.The health of digestive system can be promoted, mitigated
Gastrointestinal disorders, make skin is more healthy, the gentle solution of prevention is serious antimigraine, stimulate circulation, making drop in blood pressure, alleviating diarrhoea
Phenomenon, the malaise symptoms for mitigating Meniere's syndrome (Menieres syndrome);Make one physical efficiency is fully increased using food
Energy, treatment oral cavity, lip inflammation, prevent halitosis, reduction cholesterol and triglyceride.
Pantothenic acid:Pantothenic acid is exactly vitamin B5, pantothenic acid, is a kind of water-soluble B vitamin, pantothenic acid tool manufacture antibody work(
Can, also played an important role in terms of hair, skin and blood health is safeguarded;Generally accepted pantothenic acid and hair, the nutrition of skin
State is closely related, is when hair lacks gloss or becomes sparse, and many supplement pantothenic acid are when its visible effect.Major function can be made
Make and update bodily tissue, help wound healing, manufacture antibody, resist infectious disease, prevent fatigue, help resistance to compression, mitigation a variety of
Antibiotic side effect and toxin, nausea of releiving.
Choline:And for pregnant woman, whether the intake of choline is enough, then the brain development of fetus is influenced whether.From bosom
Start within pregnant 25 weeks, the hippocampus of supervisor's people's memory germinates, and is continued until child 4 years old.So, if in hippocampus
There is choline shortage in early development, pregnant woman, may result in the nerve cell apoptosis of fetus, and newborn brain cell is reduced, and then is influenceed
To brain development.
Biotin:Biotin, also referred to as w factor, are the important nutrients of our human bodies, if human body lacks biological
Element, can suffer from a series of disease, and the health care belt to patient carrys out very big influence.Research finds that about 50% pregnant woman lacks
Biotin.Because their shortages inform a kind of enzyme of the how proper use of biotin of body, and therefore metabolic function is caused to reduce.
But, pregnant woman's also unsuitable overdose biotin, because there is the risk for causing miscarriage.
Vitamin C:The brain function that vitamin c can improve tire baby is keen, and the hemopoietic system of tire baby is perfected
Enhancing with Abwehrkraft des Koepers has facilitation.If ready-to-be mother's pregnancy period famine vitamin C, is susceptible to suffer from scurvy.Rationally
Replenishing vitamins C be all in itself very important with fetus to pregnant woman.Because vitamin C is must during embryo growth and development
One of indispensable nutrient is particularly rapid, it is necessary to supplement enough vitamin in mid pregnancy embryo growth and development.Gestation
During Determination of Vitamin C in maternal blood be gradually reduced, be only the half of pregnant early stage during childbirth, at this moment serious intake
Not enough ready-to-be mother easily falls ill, and thus ascorbic supplement is timely.
Docosahexaenoic acid:There is the DHA (docosahexaenoic acid) of the title of " docosapentaenoic acid ", be that nerve synapse development must
Need, it is beneficial to fetal brain and neurodevelopment, contribute to brain, the neurodevelopment of baby, be conducive to the eyesight of baby.
Calcium:Human body is sought after inorganic salts (mineral matter), and ready-to-be mother is more indispensable, and the effect of particularly calcium is even more important.Often
Individual pregnant woman is required for replenishing the calcium, and pregnant woman needs 40 grams of calcium in whole period of gestation, and in pregnant late period, lower limb cramp occur in some pregnant woman.
Because the generation and development and mother's physiological metabolism of fetus bone tissue are required to substantial amounts of calcium, if the content of calcium in diet is not enough
Or lack sunshine etc., it can all cause ready-to-be mother's blood calcium to decline.Because the calcium needed for fetus is only obtained from parent, i.e.,
Make parent calcium deficiency, fetus still will draw quantitative calcium from parent, and this this may result in ready-to-be mother's bone and tooth decalcification, draws
Waist disease, leg disease, bone pain, tetany and loss of tooth etc. are played, malacosteon, pelvis deformation are also occurred that when serious, even
Cause difficult labour.Calcium is also critically important to nervous system, and when Determination of Calcium in Serum content is reduced, ready-to-be mother's nerve excitability increases, then
Muscle is twitched, here it is described " cramp " usually.Meanwhile, fetus calcium deficiency can cause fetal bone depauperation, cause
Congenital rickets etc..So, it is considerable that the pregnancy period replenishes the calcium in time.
Magnesium:Function of the magnesium to human body:The main function of magnesium ion is to allow the cell of injury to be repaired, in addition, it
Bone and tooth can be allowed to generate firmer, adjustment cholesterol and the brain development for promoting fetus.Doctor says that magnesium also has a spy
Point, be exactly period of gestation if the hypertension of pregnancy, doctor can add a little magnesium in drop, allow flesh in symptom management
Meat, which reaches, loosens purpose.If pregnant woman's magnesium content is too low, easily trigger uterine contractile, cause premature labor.Opposite, pregnant woman's content of magnesium is too
Height, is easy for causing magnesium to be poisoned, severe patient, it is also possible to suppress pregnant woman's breathing and heartbeat, so to pay special attention to during supplement magnesium.
Zinc:Period of gestation, fetus to zinc the need for measure and increase sharply, therefore pregnant woman needs to increase the supplement of zinc, to ensure
Parent zinc nutrition balances the normal development with child.In fact, zinc is begun to the influence that fetal intelligence is developed from initially.I
Know, development of fetus is that embryonated egg is bred by mitosis at first, and tissue and organ are gradually developed into intrauterine,
And it is mitotic on condition that DNA replication dna and rna transcription, zinc be then DNA replication dna, rna transcription and enzyme needed for nucleic acid synthesis must
Need constituent.First 3 months of gestation, fetus is very sensitive to various chemical factors, if pregnancy women zinc-deficiency, it is easy to lead
Cause development of fetus bad or deformity.Brain is that a most fast organ earliest is developed in all organs of fetus, and mother is pregnant 18 days,
Neuropile can be recognized in embryo;Later stage of pregnancy, fetal brain average minute clock is thin by nearly 20,000 nerves of differentiation and proliferation
Born of the same parents.Due to zinc can promote cranial nerve cell division, growth and regenerate, so if pregnant woman because Zinc Nutrition Status is bad and caused by
Fetal brain nerve cell number is reduced, and this influence be able to not will be retrieved.It is reported that the fetus of zinc deficiency, has after birth
30% is feeblemindedness.
Selenium:United States Medicine worker has found that selenium can when studying selenium with the gestational period, women breast-feeding their children and neonatal relation
Pregnant woman's blood pressure is reduced, oedema is eliminated, improves vascular conditions, hypertension of pregnancy disease is prevented and treated, suppresses the canceration of gynecological tumor.
In addition fetus teratogenesis can also be prevented.Domestic research confirms that pregnant woman's blood Se content is less than Newborn, also, pregnant woman
Woman's blood Se content is gradually reduced with the gestational period.Reduced as far as possible during childbirth, there is the pregnant of the pregnant medical history such as miscarriage, premature labor, stillborn foetus
Woman's blood Se content is significantly lower than without this medical history person again.The research of Federal University Er Chong hospitals of Germany shows, during baby due, blood
Selenium level is very low, needs to absorb substantial amounts of selenium from breast milk in time, to ensure that baby normally grows.The neonatal battalion of prevention
Support retardance and ensure the normal development of brain, this just makes the Se content of breast milk seem particularly important.Therefore, the gestational period and nursing period
The appropriate selenium of women's daily iron supplement, is highly beneficial to neonate and the health of itself.How selenium-supply is good by pregnant woman, and amount must
Suitably, if it exceeds needed by human body, it is possible to can trigger pneumonia, the illness such as Liver and kidney function is degenerated, and jeopardize the life of fetus.
If taking in substantial amounts of selenium, it can also cause to seriously endanger to body.
The auxiliary material is included in sucrose, lactose, glucose, starch, cellulose etc..
Pregnant woman and the wet nurse nutritious supplementary pharmaceutical easily brews form with particle, powder or paste etc. to be present.
The container of exotic material of the present invention, the wall of the container is pressed into in special " chevron shaped "
Fall into structure, the bottom of container is pressed into caves in structure with special helical form, when rushing hot water by hot water drift, can produce whirlpool
Vortex, helps the dissolving and mixing of nutritious supplementary pharmaceutical powder or particle.
It is preferred that the structure of container includes vessel, the top of the vessel is provided with closure, and bottom is provided with outlet,
The outlet is sealed by encapsulant, and the lateral wall of the vessel is provided with oblique groove and neck, the vessel
The position corresponding with the oblique groove is fin on madial wall.
The oblique groove is in the arrangement of falling herringbone, and the fin corresponding with the oblique groove is also in the arrangement of falling herringbone.
The bottom of the vessel is provided with helical groove, and the madial wall of vessel is close in one end of the helical groove
Arrangement, the other end extends to outlet.
Top and bottom in the vessel are respectively equipped with a filter.
The closure includes three-layer sealed film, and three-layer sealed film is respectively CPP films, aluminium film and PET film from inside to outside.
The madial wall of the container is provided with oblique fin, and when hot water is out of top injection vessel, hot water can
Flowed along fin, enhance stirring action of the current to content, so that hot water mixes more abundant with content, keep away
The waste of content is exempted from.
High-temperature resistant container of the present invention, wherein high temperature resistant refer to temperature more than 120 DEG C, 150-180 DEG C of preferable temperature.
The exotic material includes but is not limited to:Polythene PE, polypropylene PP (fusing point is up to 167 DEG C), expandable polystyrene EPS
(heat-resistant deforming temperature is up to more than 280 DEG C), PEN/PET polyethylene naphtalates, the ethylene-vinyl alcohol containing high barrier material are total to
One kind or several in polymers EVOH, Vingon PVDC, nylon MXD 6, the multilayer materials of Si oxide evaporation film etc.
Kind, optimal ethylene PE, polypropylene PP, such packing plastics is in addition to good processability, without toxicity, and topmost feature is
Heat-resistant deforming temperature is up to more than 150 DEG C, and these material requirements are in the case of 120 DEG C, 1O-20min sterilizations or heating, outward appearance
Shape, quality are without obvious change, without noxious material dissolution.The boiling water of boiling is poured, packing box will not also be deformed, thus energy
The local flavor of food is kept completely.The features such as container has high temperature resistant, anti-embrittlement, protection against the tide, anti-oxidant, UV radiation, bag
Dress food does not produce damaged container, content leaks and microorganism secondary pollution and light and heat in storage process makes content
Rotten situations such as
The application method of the product of the present invention:It can be positioned in special machine, with high pressure boiling water brewing, rush well-done soup
Liquid is convenient to flow out.
The upper and lower surface of vessel of the present invention can be punctured by the puncturing head of special construction;It is resistant to 15BAR boiling
Water brewing, realizes extraction function;Container shapes make in boiling water brewing, and vortex can be produced in container, accelerate capsule contents
Dissolving;Solution rotating in container can be driven in matched specific function machine (i.e. apparatus mentioned above) inner rotation
Mixing, accelerates the dissolving and mixing of capsule contents equal
Vessel can be placed in specific machine, driven container to rotate by the special device of machine, accelerated in container
Contents melting.The nutritious supplementary pharmaceutical particle of 20-100 mesh particle size ranges coordinates the special structure of container of the present invention needing punching
During decocting, this container is put into special machine, the lancet of machine punctures closure, high-temperature high pressure water, which enters, to be held
Dissolving content in device body, by filter, the lancet of container is pierced into the other end, by being pooled to outlet, entirely
Process was completed in 1 minute, and particle is completely dissolved and noresidue.Container after use is directly discarded, and machine is not directly contacted with
The material of the inside, without cleaning robot.It is simple and convenient, it is time saving and energy saving, without cleaning robot.
Invention additionally discloses described pregnant woman and the preparation method of wet nurse's nutritious supplementary pharmaceutical product, comprise the following steps:
(1) prepared without fishy smell, without ANFs protein powder;
(2) prepared by core nutrient premixed powder;
(3) prepared by selective nutrient premixed powder;
(4) step (1) protein powder and step (2) core nutrient and the selective nutrient mixing of step (3), obtain powder
End:
(5) pelletize:Step (4) powder mixes with auxiliary material, pelletized;
(6) it is filling:The pregnant woman prepared and wet nurse are loaded in high-temperature-resistant high-pressure-resistant container with nutritious supplementary pharmaceutical particle, it is close
Envelope.
Described in above-mentioned steps (1) following two methods can be used without fishy smell, without the preparation of ANFs protein powder.
The addition of good protein powder can calculate raw material dosage according to the content of the protein component in good protein powder raw material,
The content of protein component in the good protein powder raw material consumption=protein addition ÷ good protein powder raw materials.
A. soyabean protein powder is commercially available, and soyabean protein powder purchased in market has to comply with GB/T 22493-2008 requirements, table 5-7
Described in require.
The soyabean protein powder organoleptic requirements of table 5
Project | Quality requirement |
Form | Powder, no caking phenomenon |
Color and luster | White is to light yellow |
Smell | With the intrinsic smell free from extraneous odour of soyabean protein powder |
Impurity | The foreign substance being visible by naked eyes |
The soyabean protein powder quality annotation of table 6
The soyabean protein powder sanitary index of table 7
The soyabean protein powder for meeting above-mentioned quality requirement is chosen, fishy smell in protein powder, passivation are eliminated using physical method
ANFs, preferably heat treatment method.Heat treatment method includes:
Steam heats:Handled including normal pressure steam treatment and high-pressure water vapor.Normal pressure steam treatment is will be big
After beans pulverize and sieve, mixed with vapours rapidly, reach moistureIn 90-100 DEG C of normal heating processingRapid cooling, you can inactivate lipoxidase, finished product better flavor eliminates raw meat in protein powder
Taste, passivation ANFs, and improve the nutritive value of product.High-pressure water vapor processing is after soybean is pulverized and sieved, extremely
In pressure cooker, 110-130 DEG C of temperature, 10-20 minute, pressure 80-110kPa can eliminate fishy smell in protein powder, be passivated anti-battalion
Support the factor.
Spray hot wind passivating technique:Temperature is 230-310 DEG C of the direct spray treatment soyabean protein powder of hot blast, can be by fat
Oxidizing ferment and ANFs passivation.
The instantaneous high-temperature that pressurizes is handled:When soy meal is by shelltube heat exchanger, pressure is adjusted to 2Kg/cm2, and in 130
DEG C heat 2 seconds, be cooled to room temperature immediately afterwards, can effectively remove beany flavor, passivation ANFs, and soybean protein
Substantially it is undenatured.
Hot water milled processed:In the warm water that people's beans are first immersed to 40 DEG C or so, adding hot water makes its temperature reach 80-100
DEG C, and slurry, rapid passivation lipoxidase and ANFs are ground to form at such a temperature, and gained soya milk product is substantially without beans
Fishy smell.
Xeothermic Passivation Treatment:While big bean crushing is removed the peel, steam is xeothermic to 100 DEG C, by lipoxidase and can resist
Trophic factors is passivated.After cooling, add water toExtrusion cooking is carried out again.And through journeys such as drying, cooling, millings
Sequence, produces the soy meal of better flavor.
Blanching treatment:Full soybean is handled through water blancing can also be passivated lipoxidase and ANFs.For dry
Dry soybean, with 10 times of amount boiling water, need to heat 20 minutes.And with the soaking soybean of 4 hours of water, then blanching 10 minutes
Reach the purpose of smelling removal.It should be stirred vigorously during blanching treatment, to promote the transmission of heat, the de- beany flavor of enhancing and the anti-battalion of passivation
Support factorial effect.
Microwave heating treatment method:The characteristics of microwave is heated is to effectively supply heat energy, but does not change containing for soybean material
Water, and can elevate the temperature rapidly, so that effectively passivation fatty acid oxidase and ANFs.Microwaved mistake
The basic free from beany flavor of soybean.
General heating method can effectively remove unstability ANFs, but can not remove the soybean protein of heat endurance
Powder antigen and flatulence factor, and mesh, often occur underheat and excessively etc. phenomenon.Underheat can not eliminate anti-battalion
The factor is supported, over-heating can then destroy amino acid (lysine, arginine and part sulfur-containing amino acid) and vitamin;Heating process
In can also cause amino acid and carbohydrate to react, such as lysine and reducing sugar reaction generate insoluble compound, cause egg
White matter digestibility declines.Not enough for general heating method, the present invention preferably steam heats and spray hot wind Passivation Treatment.Heat
Wind, which sprays passivating technique and steam heating, has the heat treatment short time short, can both make in soyabean protein powder to thermo-responsive
ANFs activity eliminate, protein chain can also be deployed, amino acid residue exposure, make it easy to by egg in body
White enzyme hydrolysis.Prolonged heating is avoided to cause amino acid to be reacted with carbohydrate simultaneously, such as lysine and reducing sugar reaction
Insoluble compound is generated, causes protein digestibility to decline.
In order to reach the protein for obtaining high-quality, preferably soyabean protein powder, including following step are prepared by following methods
Suddenly:
1. dry type is heat-treated:After defatted soy flour addition water, dry type heat treatment;
2. extract:Extracted using vertical type multifunctional dynamic extraction pot, the soy meal after dry type heat treatment, after addition distilled water
Extract, be stirred continuously it is lower boiled, it is this hydrolysis with extraction process in, often produce foam, be subsequently cooled to room
Warm liquid phase mixture;
3. separation of solid and liquid:Liquid phase mixture is filtered or centrifuged, and obtains filtrate or supernatant;
4. decompose:Filtrate or centrifuged supernatant are boiled, stirring is until filtrate becomes muddy and produces precipitation, and boiling time should
The score solution liquid untill no longer producing precipitation;5. separation of solid and liquid:Using centrifugal filtration process, filtration method or dehydrator are inhaled by decomposition
Granule in liquid separation of solid and liquid, suspended liquid, obtains the filtrate containing soluble component;
6. it is spray-dried:Filtrate containing soluble component is spray-dried (190-200 DEG C of EAT, temperature of outgoing air
85 DEG C), obtain no fishy smell, the water-soluble soybean protein powder without ANFs.
1. above-mentioned steps are added after 2-5% distilled water described in dry type heat treatment to defatted soy flour, are put into rotary kiln and are entered
Row dry type is heat-treated, and temperature is 110-120 DEG C, and the time needs 1-2 hours;
Above-mentioned steps 2. extract described in dry type heat treatment after soy meal, addition distilled water after extract, material-water ratio is 1:
6-10 (preferably 1:8), be stirred continuously it is lower boiled up to more than 6 hours, be subsequently cooled to room temperature and obtain liquid phase mixture.At this
Plant in hydrolysis and extraction process, often produce foam
Filtered, or just poured into after cooling in sedimentator after above-mentioned 3. liquid phase mixture described in separation of solid and liquid cooling,
Liquid phase and residue containing nutrition composition are separated into obtain filtrate or centrifuged supernatant.This filtrate or centrifuged supernatant are one
Plant with dark and-fixation gas turbidness liquid;In addition to containing protein and various amino acid, also containing various mineral constituents
(magnesium, calcium, manganese, iron etc.), carbohydrate, the catabolite of lecithin and lecithin, the sexavalence phosphate of cephalin and inositol.
Above-mentioned that 4. filtrate or centrifuged supernatant are boiled described in decomposition, continuously stirring makes filtrate change muddy and produces to sink
Form sediment.The boiling stage can promote the dissolving of the useful soluble component of soybean;Continuously stir step by the protein in filtrate and
Amino acid is separated.Untill described boiling time should no longer be produced according to precipitation.It is preferred that boiling 3 hours.In order to control now institute
The foam of generation, can adjust the temperature of heating.
Granule in above-mentioned 5. separation of solid and liquid in preferred dehydrator suspended liquid, obtains the filtrate containing soluble component.
Above-mentioned 6. the spray drying kind spray drying, 190-200 DEG C of EAT, 85 DEG C of above-mentioned steps of temperature of outgoing air
(2) mixing of core nutrient described in, wherein core nutrient is commercially available, can be calculated according to the active constituent content of raw material
Certain core nutrient effectively contains in raw material dosage, the core nutrient raw material dosage=certain core nutrient addition ÷ raw material
Amount.
Above-mentioned steps (3) selectivity nutrient can calculate raw material dosage, from the market according to the active constituent content of raw material
The suitable raw material of selection simultaneously determines its active constituent content, presses the conversion of column count formula:Raw material dosage=certain nutrient addition
Certain nutrient effective content in ÷ raw materials.
Above-mentioned steps (4) protein powder, core nutrient, selective nutrient are proportionally mixed, and obtain powder:
Above-mentioned steps (5) are pelletized:Pelletized using dry or wet, preferably dry granulation, add auxiliary material, other special requirements
Nutritional ingredient and appropriate flavouring, aromatic;The weight ratio of the auxiliary material and step (4) powder is 1-5:1 (preferably 2.3:
1);The auxiliary material is included in sucrose, lactose glucose, starch, cellulose etc..
It is filling in above-mentioned steps (6):In the production line with nontoxic inert gas (nitrogen or carbon dioxide etc.) protection
On, quantitatively tamp pregnant woman and wet nurse uses nutritious supplementary pharmaceutical particle using Machine automated, closure passes through the modes such as heat seal and appearance
Device is combined, it is ensured that sealing, and the inert gases such as nontoxic nitrogen or carbon dioxide are filled with container.
Present invention also offers the pregnant woman and wet nurse the application of pregnancy complication anaemia is being reduced with nutritious supplementary pharmaceutical.
Beneficial effects of the present invention are illustrated by following test examples
The pregnant woman of test example one and wet nurse's hypoferric anemia and its controlling experiment
Prescription:
Treatment method:10 hospital diagnosis are volunteer (the Excluded cases non-iron deficiency anemia, or iron-deficient of pregnant woman anemia
Anaemia pole severe person;Allergic constitution and those who are allergic to this drug;Merging angiocarpy, the cerebrovascular, liver, kidney and hemopoietic system, other are serious
Primary disease, mental patient;Protopathy is not controlled, continuous bleeding Anemia) , AgeTake after mixing it with water above-mentioned
Nutritious supplementary pharmaceutical, 2 times a day, 1 every time, and 30 days are 1 course for the treatment of, does not take other liter of blood during medication, mends iron medicine.
Criterion of therapeutical effect:It is effective (clinical symptoms are clearly better, severity of anemia classification by severe switchs to slightly, improvement 2 grades with
On), effectively (clinical symptoms take a favorable turn, severity of anemia improve 1 grade), invalid (clinical symptoms and severity of anemia without improve).
Clinical observation shows, above-mentioned nutritious supplementary pharmaceutical treats status of iron deficiency in pregnant women, effective 9, wherein effective 6.
Two pregnancy period of test example different phase selects influence of the nutrient prime replenisher to pregnant mouse
Prescription:
Zoopery
Adult healthy cleaning grade female rats (Wistar) 75 (210~230g of body weight), male rat 30 (280~
300g).Male and female rat quantity presses 2:1 is mated, and pregnant mouse 50 is obtained altogether.According to the difference for giving sample time, by Pregnant rats
It is divided into pregnant preceding group (i.e.:Start to gavage sample within 1 week before mating), pregnant early stage group, second trimester group, totally 5 groups of pregnant late period and control group,
Every group 10.Above-mentioned nutritious supplementary pharmaceutical is given through gavage by 0.1g/kg.bw, gavage amount is that 1.0ml/kg.bw control groups are gavaged
The physiological saline of amount.(2) food ration and body weight of pregnant mouse were weighed every 3 days.Record the fetus sum of spontaneous labor, live births,
Stillborn foetus number, monster number, measure its growth indexes:It is height (head stern length), tail length, body weight, nose heave.(3) pregnant mouse blood, separation are gathered
Serum, using atomic absorption spectroscopy determination calcium, magnesium, iron, zinc content.(4) weigh fetus tissue and digest, determine tire
Young Calcium In Tissues, magnesium, iron, the content of zinc.
Results of animal shows, pregnant preceding group, the pregnant mouse body weight increase amount of pregnant early stage group pregnant early stage apparently higher than
Control group (P<0.05);The pregnant mouse body weight total augment weight amount that above-mentioned nutritious supplementary pharmaceutical is given during second trimester is significantly higher than other each groups (P
<0.05).From each group farrowing quantity, the pregnant mouse litter size of each group for giving above-mentioned nutritious supplementary pharmaceutical is more than control group, and difference has
Statistical significance (P<0.05).Pregnancy period give above-mentioned nutritious supplementary pharmaceutical each group fetus Calcium In Tissues content be above control group and
Pregnant preceding supplementation group (P<0.05);The fetus tissue content of magnesium of group and second trimester group is higher than control group (P before pregnant<0.01,P<0.05);
The Zn content of pregnant late period group is higher than other each groups (P<0.05).
The ANFs degree of passivation assay method of test example three
When being heat-treated, it is necessary to assure the intensity of heat treatment is suitable.Then ANFs destruction is inadequate for underheat;Plus
Hot excessively then rate of ultilization of amino acid declines, and can reduce the biological efficiency of protein.It is many to determine urease activity in actual production
Judge the degree of passivation of the tryptose factor, react underheat;Using protein solubility as judging albumen powder over-heating
Index.
Urease activity is determined:The optimum condition of urease activity in nutritious supplementary pharmaceutical (albumen powder) is determined using nessler reagent
For:Wavelength 415nm, developer consumption 1mL, urea concentration 3%, 35 DEG C of reaction temperature, reaction time 7min.Nutritious supplementary pharmaceutical
The best use of pH of urase is 7.0 in (albumen powder), and optimal reactive temperature is 35 DEG C, and urase stores 3h between 25~40 DEG C to be had
Preferable heat endurance, enzyme activity retention rate is more than 80%.Urase is tried to achieve using Lineweaver-Burk double-reciprocal plot methods
Vmax is 0.17mmol/min, and Km is 0.017mol/L.
Protein solubility is determined:The 1.5g albumen powders after finely ground (60 mesh) are weighed in 250mL beakers, are added
75mL, 0.2%KOH solution, stir 20min in magnetic stirring apparatus.50mL liquid is gone in centrifuge tube again, with per minute
2700r centrifugations 10 minutes.Aspirate supernatant 15mL, with Kjeldahl nitrogen determination protein content therein.This content phase
When the albumen quality dissolved in 0.3 gram of original sample.
Protein solubility (PS) is calculated as follows:
PS (%)=(V-V0) * C*0.014*6.25/0.3*100%
In formula:
PS --- protein solubility, %;
C --- hydrochloric acid standard solution concentration, mol/L;
V --- required standard acid volume (mL) during titration sample
V0 --- required standard acid volume (mL) during titration blank
As PS > 85%, then it is assumed that albumen powder heats not enough;And as PS < 75%, then it is assumed that albumen powder is heated
Overtreating;And PS is at 75%~85% or so, then it is assumed that the quality of albumen powder is preferable.
As a result table, 8
The spray hot wind passivation temperature of table 8 is to ANFs activity influence
Soyabean protein powder sequence number | Temperature (DEG C) | Urease activity | Protein solubility |
1 | 200 | 3 | 91% |
2 | 230 | 0 | 85% |
3 | 300 | 0 | 82% |
4 | 310 | 0 | 80% |
5 | 320 | 0 | 75% |
As a result, hot blast direct spraying processed soybeans albumen powder of the present invention at 230-310 DEG C, sprays good passivation effect, greatly
It is high to the active elimination factor of thermo-responsive ANFs in legumin powder.
The package materials selection of test example four
Consider from packaging for foodstuff angle, shelf of this form of capsule stated clearly with the present invention as carrier than other forms
Phase is longer.Shelf life is all vital to the food enterprises and consumer.The present invention is directed to the influence of Food Shelf-life
Factor (product in itself and its function, environment and packaging material etc.) takes corresponding measure.(1) shelf life is by product
The influence of microorganism, enzyme and biochemical reaction.Some harmful substances or microorganism that microorganism itself produces make use of in product
Some nutritional ingredients generation other materials, so as to have impact on the shelf life of product.The nutritious supplementary pharmaceutical powder (particle) of the present invention
Corresponding sterilizing measure is employed before packing, is dispensed in the cleaning shop for meeting GMP requirements, full of inert gas
Sealed in space capsule, it is ensured that product is in itself without microorganism pollution.Substantial amounts of data shows that the effect of enzyme is to cause shelf life
The major reason of problem, nutritious supplementary pharmaceutical powder (particle) of the invention employs corresponding enzyme high-temperature inactivation measure before packing,
Ensure that inactive enzyme exists product in itself.Change in terms of biochemistry focuses on to show in oxidation reaction, and biochemical reaction is main
Influence the outward appearance of product, local flavor and mouthfeel.The nutritious supplementary pharmaceutical powder (particle) of the present invention is in the space capsule full of inert gas
Sealed, capsule is gathered using high temperature resistant, air-locked material polythene PE, polypropylene PP (fusing point is up to 167 DEG C), expandability
Styrene EPS (heat-resistant deforming temperature is up to more than 280 DEG C), PEN/PET polyethylene naphtalates, the second containing high barrier material
In alkene-ethenol copolymer EVOH, Vingon PVDC, nylon MXD 6, the multilayer materials of Si oxide evaporation film etc.
It is middle a kind of or a kind of, closure includes three-layer sealed film, and three-layer sealed film is respectively CPP films, aluminium film and PET from inside to outside
Film.The sealed sealed capsule of lid thermal coupling can ensure that product no oxygen itself, will not occur redox reaction.(2) influence
The environmental factor of shelf life has:Storage temperature, relative humidity, moisture etc..(3) different packaging materials its breathe freely
Property, sealing, translucency, hinder moist etc. all different, so as to influence the shelf life of product.The present invention nutritious supplementary pharmaceutical powder (
Grain) capsule use high temperature resistant, air-locked material, include but is not limited to:Polythene PE, polypropylene PP (fusing point is up to 167 DEG C),
Expandable polystyrene EPS (heat-resistant deforming temperature is up to more than 280 DEG C), PEN/PET polyethylene naphtalates, material containing high barrier
Ethylene-vinyl alcohol copolymer EVOH, Vingon PVDC, the nylon MXD 6 of material, the MULTILAYER COMPOSITE of Si oxide evaporation film etc.
One or more in material, preferably polythene PE, polypropylene PP.Closure includes three-layer sealed film, and three-layer sealed film is by interior
It is respectively outwards CPP films, aluminium film and PET film.The sealed sealed capsule good airproof performance of lid thermal coupling, it is ensured that airtight, impermeable
Light, moisture barrier property are good.It see the table below 9,10:
Table 9
Table 10
Stability | The term of validity | Transport | Preservation | |
Nutritional supplementation agent capsules | It is good | More than 2 years | It is convenient | Easily |
Other nutritious supplementary pharmaceutical powder | Typically | Less than 1 year | It is inconvenient | It is not easy |
Product of the invention also has following features in summary
(1) it is convenient.Simple to operate, any one new hand can easily make one glass of safety, reeky pregnant woman and wet nurse
Use nutritious supplementary pharmaceutical.Without cumbersome cleaning, pregnant woman and wet nurse's nutritious supplementary pharmaceutical are carried out, direct returnable just can be with.
(2) safety.The supplementary material of high-quality is selected, in the factory building for meeting GMP requirements, using most stringent of similar to medicine
Standard processing procedure, pregnant woman is packed by international advanced space capsule technology and wet nurse uses nutritious supplementary pharmaceutical particle, and insert nitrogen or
The revolution sexual system of carbon dioxide etc., overwhelms the current production technology of all.Without unpacking, dress directly puts machine into, rushes
Boil, extracted after be also convenient for reclaim.
(3) it is fresh.Capsule is independent packaging, and nitrogen charging, aluminum foil is packed, and it is all fresh often to open each cup.It is complete
Under the protection of hermetically sealed inflated with nitrogen packaging, fresh, the anti-oxidation of pregnant woman and wet nurse's nutritious supplementary pharmaceutical can be effectively kept, is made
Storage life is reached 2 years as long as, because he can pass through the time of 2 years, can reach the distance of international space station, therefore he is called
Space food, when capsulae vacuus.
(4) stay in grade.Pregnant woman and wet nurse are that automation is tamped on same production line with nutritional supplementation agent capsules,
The stay in grade of every glass of pregnant woman and wet nurse's nutritious supplementary pharmaceutical can be ensured.
(5) it is steaming hot.By high pressure boiling water brewing, extraction, what is obtained is reeky pregnant woman and wet nurse's nutritional supplementation
Agent.
Brief description of the drawings
Fig. 1 is the structural representation of inventive container;
Fig. 2 is the polycrystalline substance schematic diagram in inventive container;
Fig. 3 is the sealing cover structure schematic diagram of inventive container.
Embodiment
The structure of the inventive container of embodiment 1
As shown in figure 1, inventive container includes vessel 1, the top of the vessel 1 is provided with closure 2, bottom
Provided with outlet 3, the outlet 3 is sealed by encapsulant, and the lateral wall of the vessel 1 is provided with oblique groove 4 and neck 5,
The position corresponding with the oblique groove 4 is fin on the madial wall of the vessel 1.Oblique groove 4 is constituted together with fin
The structure of outer recessed convex.When in use, the inside of vessel 1 is used for holding the contents such as ground coffee or milk tea powder the present invention
Thing, the neck 5 is used for carrying out being connected fixation with external equipment (it carries out brewing operation to container).
Inventive container, wherein the oblique groove 4 is in the arrangement of falling herringbone, the fin corresponding with the oblique groove 4
In the arrangement of falling herringbone.The fin of falling herringbone is set on the madial wall of vessel 1, can make to enter inside vessel 1
Hot water content is more fully stirred.
As shown in Fig. 2 inventive container, wherein the bottom of the vessel 1 is provided with helical groove 6, the spiral is recessed
The madial wall arrangement of vessel 1 is close in one end of groove 6, and the other end extends to outlet 3.The bottom of vessel 1 is in infundibulate,
When madial wall of the soup along vessel 1 flows to bottom, soup flows to 3 positions of outlet, flow process along helical groove 6
In, in the presence of helical groove 6, soup is rotated, and further enhances the mixability of hot water and content.
When soup collects in the outlet port of the bottom of vessel 1, encapsulant herein can be by the thimble of equipment
Pierce through, rush well-done soup and flow out from there.
Inventive container, wherein the top and bottom in the vessel 1 are respectively equipped with a filter 7.Filter 7 is
Paper filter, bulky grain, impurity that can be in filter water and content etc.;Can also be without filter, no filter only influences
Outward appearance and mouthfeel, do not influence nutrition and taste.
As shown in figure 3, inventive container, wherein the closure 2 includes three-layer sealed film, three-layer sealed film is from inside to outside
Respectively CPP films 201, aluminium film 202 and PET film 203.Wherein, CPP films 201 can set up sealedly first road barrier, aluminium film 202
Completely isolated water and air, PET film 203 can strengthen sealing effectiveness.
The madial wall of inventive container is provided with oblique fin, when hot water is out of top injection vessel 1, hot water energy
It is enough to be flowed along fin, stirring action of the current to content is enhanced, so that hot water mixes more abundant with content,
Avoid the waste of content.
The upper and lower surface of vessel 1 in the present invention can be punctured by the puncturing head of special construction;It is resistant to 15BAR boiling water
Brewing, realizes extraction function;Container shapes make in boiling water brewing, and vortex can be produced in container, accelerate the molten of capsule contents
Solution;In matched specific function machine (i.e. apparatus mentioned above) inner rotation solution rotating in container can be driven to mix
Close, accelerate the dissolving of capsule contents and be well mixed.
Vessel 1 can be placed in specific machine, driven container to rotate by the special device of machine, accelerated container
Contents melting.The wall of the container is pressed into be caved in structure with special " chevron shaped ", and the bottom of container is pressed into
Caved in structure with special helical form, when rushing hot water by the special hot water drift of particular machine, eddy-currents can be produced (as schemed
2) dissolving and mixing of capsule 's content, are contributed to.
Bulky grain, impurity in paper filter setting up and down 7 in vessel 1, filter water and content etc., it is middle
The content of sequence processing is placed through, closure 2 is combined by the modes such as heat seal and vessel 1, it is ensured that filled in sealing, container
The inert gases such as nontoxic nitrogen or carbon dioxide are filled up, play a part of extending the shelf life sterilizes again.Need brewing soup
When, this container is put into special machine in (such as capsule type coffee machine or capsule soy bean milk making machine), the lancet of machine will be close
Capping 2 is punctured, and high-temperature high pressure water enters dissolving content in vessel 1, and by filter, container is pierced into the other end
Lancet, by being pooled to outlet, one glass of giving off a strong fragrance delicious nutritious supplementary pharmaceutical, coffee or soya-bean milk are formed from the inflow of outlet 3 cup.
Whole process is 1, completed in 2 minutes.Container after use is directly discarded, and machine is not directly contacted with the material of the inside, without clear
Washing machine device.It is simple and convenient, it is time saving and energy saving, without cleaning robot.
Embodiment 2 is prepared without ANFs good protein powder
1. dry type is heat-treated:Defatted soy flour is added after 2% distilled water, rotary kiln is put into and carries out dry type heat treatment, temperature
Spend for 110 DEG C, the time needs 2 hours;
2. extract:Extracted using vertical type multifunctional dynamic extraction pot, the soy meal after dry type heat treatment, after addition distilled water
Extract, material-water ratio is 1:8.Be stirred continuously it is lower boiled up to more than 6 hours, it is this hydrolysis and extraction process in, often
Foam can be produced.It is subsequently cooled to room temperature.
3. separation of solid and liquid:Filtered, or just poured into after cooling in sedimentator after liquid phase mixture is cooled down, battalion will be contained
The liquid phase and residue for supporting component are separated.
4. decompose:Filtrate is boiled, to promote the dissolving of the useful soluble component of soybean;In order in filtrate
Protein and amino acid are separated, and this filtrate is boiled in autoclave pan, and continuously stirs.Now, filtrate becomes muddy and produced
Precipitation, boiling time should typically be needed 3 hours or so untill no longer producing precipitation.
5. separation of solid and liquid:Using the granule in centrifugal filtration process, suspended liquid, the filtrate containing soluble component is obtained.
6. it is spray-dried:Filtrate containing soluble component is spray-dried (190-200 DEG C of EAT, temperature of outgoing air
85 DEG C), obtain no fishy smell, the water-soluble soybean protein powder without ANFs.
Embodiment 3 is prepared without ANFs good protein powder
1. dry type is heat-treated:Defatted soy flour is added after 5% distilled water, rotary kiln is put into and carries out dry type heat treatment, temperature
Spend for 120 DEG C, the time needs 1 hour;
2. extract:Extracted using vertical type multifunctional dynamic extraction pot.After soy meal after dry type heat treatment, addition distilled water
Extract, material-water ratio is 1:10.It is being stirred continuously lower boiled up to more than 6 hours;
3. separation of solid and liquid:Filtered, or just poured into after cooling in sedimentator after liquid phase mixture is cooled down, battalion will be contained
The liquid phase and residue for supporting component are separated;
4. decompose:Filtrate is boiled, to promote the dissolving of the useful soluble component of soybean;In order in filtrate
Protein and amino acid are separated, and this filtrate is boiled in autoclave pan, and continuously stirs.Now, filtrate becomes muddy and produced
Precipitation, boiling time should be needed 3 hours untill no longer producing precipitation;
5. separation of solid and liquid:Using centrifugal filtration process, inhale in filtration method or dehydrator, preferably dehydrator, suspended liquid
Granule, obtains the filtrate containing soluble component.
6. it is spray-dried:Filtrate containing soluble component is spray-dried (190-200 DEG C of EAT, temperature of outgoing air
85 DEG C), obtain no fishy smell, the water-soluble soybean protein powder without ANFs.
Embodiment 4 is prepared without ANFs good protein powder
Satisfactory albumen powder is bought, after sieving, is mixed with vapours rapidly, reaches moisture In
90-100 DEG C of normal heating processingMinute, rapid cooling, you can inactivate lipoxidase, finished product better flavor,
Fishy smell in protein powder, passivation ANFs are eliminated, and improves the nutritive value of product.High-pressure water vapor processing be by
After soybean pulverizes and sieves, into pressure cooker, 110-130 DEG C of temperature, 10-20 minute, pressure 80-110kPa can eliminate protein
Fishy smell, passivation ANFs in powder.
Embodiment 5 is prepared without ANFs good protein powder
Satisfactory albumen powder is bought, can in the direct spray treatment soyabean protein powder of hot blast that temperature is 232-310 DEG C
Lipoxidase and ANFs are passivated.
Embodiment 6 is prepared without ANFs good protein powder
Satisfactory albumen powder is bought, after sieving, into pressure cooker, 110-130 DEG C of temperature, 10-20 minute, pressure
80-110kPa, can eliminate fishy smell in protein powder, passivation ANFs.
Embodiment 7
Component table
Pregnant woman is well mixed with powder in upper table, and pregnant woman, which is made, using preferred dry granulation uses nutritious supplementary pharmaceutical particle,
On the production line protected with nontoxic inert gas (nitrogen or carbon dioxide etc.), pregnant woman is quantitatively tamped using Machine automated
Nutritious supplementary pharmaceutical particle is used, closure is combined by the modes such as heat seal and container (embodiment 1), it is ensured that filled in sealing, container
The inert gases such as full nontoxic nitrogen or carbon dioxide.
Wet nurse is well mixed with powder in upper table, and wet nurse, which is made, using preferred dry granulation uses nutritious supplementary pharmaceutical particle,
On the production line protected with nontoxic inert gas (nitrogen or carbon dioxide etc.), wet nurse is quantitatively tamped using Machine automated
Nutritious supplementary pharmaceutical particle is used, closure is combined by the modes such as heat seal and container (embodiment 1), it is ensured that filled in sealing, container
The inert gases such as full nontoxic nitrogen or carbon dioxide.
Embodiment 8
Component
Pregnant woman is well mixed with powder in upper table, and pregnant woman, which is made, using preferred dry granulation uses nutritious supplementary pharmaceutical particle,
On the production line protected with nontoxic inert gas (nitrogen or carbon dioxide etc.), pregnant woman is quantitatively tamped using Machine automated
Nutritious supplementary pharmaceutical particle is used, closure is combined by the modes such as heat seal and container (embodiment 1), it is ensured that filled in sealing, container
The inert gases such as full nontoxic nitrogen or carbon dioxide.
Wet nurse is well mixed with powder in upper table, and wet nurse, which is made, using preferred dry granulation uses nutritious supplementary pharmaceutical particle,
On the production line protected with nontoxic inert gas (nitrogen or carbon dioxide etc.), wet nurse is quantitatively tamped using Machine automated
Nutritious supplementary pharmaceutical particle is used, closure is combined by the modes such as heat seal and container (embodiment 1), it is ensured that filled in sealing, container
The inert gases such as full nontoxic nitrogen or carbon dioxide.
Embodiment 9
Pregnant woman is well mixed with powder in upper table, and pregnant woman, which is made, using preferred dry granulation uses nutritious supplementary pharmaceutical particle,
On the production line protected with nontoxic inert gas (nitrogen or carbon dioxide etc.), pregnant woman is quantitatively tamped using Machine automated
Nutritious supplementary pharmaceutical particle is used, closure is combined by the modes such as heat seal and container (embodiment 1), it is ensured that filled in sealing, container
The inert gases such as full nontoxic nitrogen or carbon dioxide.
Wet nurse is well mixed with powder in upper table, and wet nurse, which is made, using preferred dry granulation uses nutritious supplementary pharmaceutical particle,
On the production line protected with nontoxic inert gas (nitrogen or carbon dioxide etc.), wet nurse is quantitatively tamped using Machine automated
Nutritious supplementary pharmaceutical particle is used, closure is combined by the modes such as heat seal and container (embodiment 1), it is ensured that filled in sealing, container
The inert gases such as full nontoxic nitrogen or carbon dioxide.
Embodiment 10
Pregnant woman is well mixed with powder in upper table, and pregnant woman, which is made, using preferred dry granulation uses nutritious supplementary pharmaceutical particle,
On the production line protected with nontoxic inert gas (nitrogen or carbon dioxide etc.), pregnant woman is quantitatively tamped using Machine automated
Nutritious supplementary pharmaceutical particle is used, closure is combined by the modes such as heat seal and container (embodiment 1), it is ensured that filled in sealing, container
The inert gases such as full nontoxic nitrogen or carbon dioxide.
Wet nurse is well mixed with powder in upper table, and wet nurse, which is made, using preferred dry granulation uses nutritious supplementary pharmaceutical particle,
On the production line protected with nontoxic inert gas (nitrogen or carbon dioxide etc.), wet nurse is quantitatively tamped using Machine automated
Nutritious supplementary pharmaceutical particle is used, closure is combined by the modes such as heat seal and container (embodiment 1), it is ensured that filled in sealing, container
The inert gases such as full nontoxic nitrogen or carbon dioxide.
It is foregoing to the present invention specific illustrative embodiment description be in order to illustrate and illustration purpose.These descriptions
It is not wishing to limit the invention to disclosed precise forms, and it will be apparent that according to above-mentioned teaching, can be much changed
And change.The purpose of selecting and describing the exemplary embodiment is that explaining that the certain principles and its reality of the present invention should
With so that those skilled in the art can realize and using the present invention a variety of exemplaries and
A variety of selections and change.The scope of the present invention is intended to be limited by claims and its equivalents.
Claims (10)
1. the pregnant woman and wet nurse of a kind of instant use nutritious supplementary pharmaceutical product, it is characterised in that be by nutritious supplementary pharmaceutical and resistance to
The container of high-temperature material composition is constituted;The nutritious supplementary pharmaceutical is put into exotic material container, sealing container, is filled in container
Full inert gas;The nutritious supplementary pharmaceutical includes following weight parts composition:
15~35 parts of good protein,
1~10 part of nutrient,
35~84 parts of auxiliary material.
2. the pregnant woman and wet nurse of a kind of instant as claimed in claim 1 use nutritious supplementary pharmaceutical product, it is characterised in that institute
Stating nutritious supplementary pharmaceutical includes following parts by weight ingredient:
25~30 parts of good protein,
2~5 parts of nutrient,
50~69 parts of auxiliary material.
3. the pregnant woman and wet nurse of a kind of instant as claimed in claim 1 use nutritious supplementary pharmaceutical product, it is characterised in that:Institute
The good protein stated is without fishy smell, without ANFs.
4. the pregnant woman and wet nurse of a kind of instant as claimed in claim 1 use nutritious supplementary pharmaceutical product, it is characterised in that:Institute
Stating nutrient includes core nutrient and selective nutrient, and wherein core nutrient is to be made up of following weight than component
Table 1
Wherein, selective nutrient include following weight than composition more than one.
Table 2
5. the pregnant woman and wet nurse of a kind of instant as claimed in claim 4 use nutritious supplementary pharmaceutical product, it is characterised in that:Its
Center heart nutrient is to be made up of following weight than component
The core nutrient weight ratio of table 3
Wherein, selective nutrient weight ratio is shown in Table 4
The selective nutrient weight ratio of table 4:
6. the pregnant woman and wet nurse of a kind of instant as claimed in claim 1 use nutritious supplementary pharmaceutical product, it is characterised in that institute
The wall of the container for the exotic material stated is pressed into be caved in structure with special " chevron shaped ", and the bottom of container is pressed
Caved in structure into special helical form, when rushing hot water by hot water drift, eddy-currents can be produced, the molten of nutritious supplementary pharmaceutical is helped
Solution and mixing.
7. the pregnant woman and wet nurse of a kind of instant as claimed in claim 4 use nutritious supplementary pharmaceutical product, it is characterised in that institute
Stating the structure of container includes vessel, and the top of the vessel is provided with closure, and bottom is provided with outlet, the outlet quilt
Encapsulant is sealed, the lateral wall of the vessel be provided with oblique groove and neck, the madial wall of the vessel with
The corresponding position of the oblique groove is fin;The oblique groove is in the arrangement of falling herringbone, and corresponding with the oblique groove is convex
Rib is also in the arrangement of falling herringbone;The bottom of the vessel is provided with helical groove, and container is close in one end of the helical groove
The madial wall arrangement of body, the other end extends to outlet.
8. the pregnant woman and wet nurse of a kind of instant as claimed in claim 1 use nutritious supplementary pharmaceutical product, it is characterised in that institute
90 DEG C -150 DEG C of high temperature resistant is stated, the exotic material is polythene PE, polypropylene PP, expandable polystyrene EPS, PEN/
PET polyethylene naphtalates, the ethylene-vinyl alcohol copolymer EVOH containing high barrier material, Vingon PVDC, nylon
It is one or more of in MXD6, Si oxide evaporation film.
9. the pregnant woman and wet nurse of a kind of instant are with the preparation method of nutritious supplementary pharmaceutical product, it is characterised in that including following step
Suddenly:
(1) prepared without fishy smell, without ANFs good protein powder:
(2) prepared by core nutrient premixed powder:
(3) prepared by selective nutrient premixed powder:
(4) step (1) protein powder and step (2) core nutrient and the selective nutrient mixing of step (3), obtain powder:
(5) pelletize:Step (4) powder mixes with auxiliary material, pelletized;
(6) it is filling:The pregnant woman prepared and wet nurse are loaded in high-temperature-resistant high-pressure-resistant container with nutritious supplementary pharmaceutical particle, sealing.
10. the pregnant woman and wet nurse of a kind of instant as claimed in claim 9 are with the preparation method of nutritious supplementary pharmaceutical product, its
It is characterised by comprising the following steps:
(1) prepared without fishy smell, without ANFs good protein powder, using following any mode:
A. soyabean protein powder purchased in market has to comply with GB/T 22493-2008 requirements, and the addition of good protein powder can be according to excellent
The content of protein component in matter protein powder raw material, calculates raw material dosage, the good protein powder raw material consumption=egg
The content of protein component in white matter addition ÷ good protein powder raw materials, is eliminated in protein powder using heat treatment method
Fishy smell, passivation ANFs, the heat treatment method are any as follows:
Normal pressure steam treatment:After soybean is pulverized and sieved, mixed with vapours rapidly, reach moistureIn
90-100 DEG C of normal heating processingRapid cooling, you can inactivate lipoxidase, finished product better flavor,
Fishy smell in protein powder, passivation ANFs are eliminated, and improves the nutritive value of product;
High-pressure water vapor processing:It is after soybean is pulverized and sieved, into pressure cooker, 110-130 DEG C of temperature, 10-20 minute, pressure
80-110kPa, can eliminate fishy smell in protein powder, passivation ANFs;
Spray hot wind passivating technique:Temperature is 232-310 DEG C of the direct spray treatment soyabean protein powder of hot blast, can be by fat oxidation
Enzyme and ANFs passivation;
Or the preparation process of B. soyabean protein powders includes:
1. dry type is heat-treated:After defatted soy flour addition distilled water, it is put into rotary kiln and carries out dry type heat treatment;
2. extract:Extracted, the soy meal after dry type heat treatment, carried after addition distilled water using vertical type multifunctional dynamic extraction pot
Take, be stirred continuously it is lower boiled up to more than 6 hours, be subsequently cooled to room temperature and obtain liquid phase mixed liquor;
3. separation of solid and liquid:Filtered, or just poured into after cooling in sedimentator after liquid phase mixture is cooled down, nutritious group will be contained
The liquid phase and residue divided are separated, and obtain filtrate or centrifuged supernatant;
4. decompose:Filtrate or centrifuged supernatant are boiled, to promote the dissolving of the useful soluble component of soybean;And it is continuous
Stirring is until filtrate becomes muddy and produces precipitation, and boiling time should be untill no longer producing precipitation;
5. separation of solid and liquid:Using centrifugal process, filtration method or dehydrator, the granule in suspended liquid is obtained containing soluble component
Filtrate;
6. it is spray-dried:Filtrate containing soluble component is subject to 190-200 DEG C of spray drying EAT, 85 DEG C of temperature of outgoing air,
Obtain the water-soluble soybean protein powder without fishy smell, without ANFs.
(2) prepared by core nutrient premixed powder:Core nutrient is commercially available, can be calculated according to the active constituent content of raw material
Certain core nutrient effectively contains in raw material dosage, the core nutrient raw material dosage=certain core nutrient addition ÷ raw material
Amount;
(3) prepared by selective nutrient premixed powder:According to the active constituent content of raw material, raw material dosage is calculated, from the market
The suitable raw material of selection simultaneously determines its active constituent content, presses the conversion of column count formula:Raw material dosage=certain nutrient addition
Certain nutrient effective content in ÷ raw materials;
(4) step (1) protein powder and step (2) core nutrient and the selective nutrient mixing of step (3), obtain powder:
(5) pelletize:Pelletized using dry or wet, addition auxiliary material, the nutritional ingredient of other special requirements and appropriate flavouring,
Aromatic;The weight ratio of the auxiliary material and powder is 1-5:1, the auxiliary material is included in sucrose, lactose glucose, starch, fiber
Element;
(6) it is filling:On the production line with nontoxic inert gas shielding, pregnant woman and breast are quantitatively tamped using Machine automated
Mother uses nutritious supplementary pharmaceutical particle, and closure passes through the modes such as heat seal and container combination, it is ensured that be filled with sealing, container nontoxic
The inert gas such as nitrogen or carbon dioxide.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710437705.3A CN107242576A (en) | 2017-06-12 | 2017-06-12 | The pregnant woman and wet nurse of a kind of instant are with nutritious supplementary pharmaceutical product and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710437705.3A CN107242576A (en) | 2017-06-12 | 2017-06-12 | The pregnant woman and wet nurse of a kind of instant are with nutritious supplementary pharmaceutical product and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107242576A true CN107242576A (en) | 2017-10-13 |
Family
ID=60019088
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710437705.3A Pending CN107242576A (en) | 2017-06-12 | 2017-06-12 | The pregnant woman and wet nurse of a kind of instant are with nutritious supplementary pharmaceutical product and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107242576A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107594540A (en) * | 2017-11-05 | 2018-01-19 | 耿德铨 | Help and breed nutriment composite powder and preparation method thereof |
CN107890115A (en) * | 2017-11-01 | 2018-04-10 | 苏州大学 | A kind of nutrient powder for promoting the stagnant long fetal growth of gestational diabetes and preparation method and application |
CN109288067A (en) * | 2018-10-18 | 2019-02-01 | 德瑞美医药生物技术盐城有限公司 | It is a kind of to help the pregnant nutritional preparation prevented miscarriage |
CN110122885A (en) * | 2019-06-06 | 2019-08-16 | 南通光合生物技术有限公司 | The albumen powder of the easy brew of rapid dispersion |
CN114651988A (en) * | 2022-03-23 | 2022-06-24 | 浙江科露宝食品有限公司 | Protein component formula food for special medical application and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1463745A (en) * | 2002-06-14 | 2003-12-31 | 丁强 | Replenisher containing complete nutrescin |
CN102459029A (en) * | 2009-06-04 | 2012-05-16 | 米塔卡有限责任公司 | Rigid cartridge for coffee and soluble products for preparing beverages |
CN203767334U (en) * | 2014-04-22 | 2014-08-13 | 浙江爱仕达生活电器有限公司 | Drink capsule |
CN106135425A (en) * | 2015-04-01 | 2016-11-23 | 郑路生 | The milk protein powder that a kind of applicable pregnant food in one's mouth phase is edible |
-
2017
- 2017-06-12 CN CN201710437705.3A patent/CN107242576A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1463745A (en) * | 2002-06-14 | 2003-12-31 | 丁强 | Replenisher containing complete nutrescin |
CN102459029A (en) * | 2009-06-04 | 2012-05-16 | 米塔卡有限责任公司 | Rigid cartridge for coffee and soluble products for preparing beverages |
CN203767334U (en) * | 2014-04-22 | 2014-08-13 | 浙江爱仕达生活电器有限公司 | Drink capsule |
CN106135425A (en) * | 2015-04-01 | 2016-11-23 | 郑路生 | The milk protein powder that a kind of applicable pregnant food in one's mouth phase is edible |
Non-Patent Citations (3)
Title |
---|
关海宁等: "《龙江地产农产品加工技术》", 31 January 2013, 黑龙江大学出版社 * |
张海臣: "脱腥保溶大豆蛋白粉的研究", 《郑州粮食学院学报》 * |
靳烨: "《畜禽食品工艺学》", 31 March 2004 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107890115A (en) * | 2017-11-01 | 2018-04-10 | 苏州大学 | A kind of nutrient powder for promoting the stagnant long fetal growth of gestational diabetes and preparation method and application |
CN107594540A (en) * | 2017-11-05 | 2018-01-19 | 耿德铨 | Help and breed nutriment composite powder and preparation method thereof |
CN109288067A (en) * | 2018-10-18 | 2019-02-01 | 德瑞美医药生物技术盐城有限公司 | It is a kind of to help the pregnant nutritional preparation prevented miscarriage |
CN110122885A (en) * | 2019-06-06 | 2019-08-16 | 南通光合生物技术有限公司 | The albumen powder of the easy brew of rapid dispersion |
CN114651988A (en) * | 2022-03-23 | 2022-06-24 | 浙江科露宝食品有限公司 | Protein component formula food for special medical application and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107242576A (en) | The pregnant woman and wet nurse of a kind of instant are with nutritious supplementary pharmaceutical product and preparation method thereof | |
CN101297685B (en) | Functional tofu jelly powder and preparation method thereof | |
CN106490605A (en) | A kind of hypertension of pregnancy tailored version clinical nutrition formula and preparation method thereof | |
CN109122902A (en) | A kind of baby formula milk powder and preparation method thereof containing lutein | |
CN101703227A (en) | Lactogenic soup | |
CN105494577A (en) | Nutrient easy-to-digest biscuits for preschoolers to eat | |
CN108967795A (en) | A kind of deer hemepeptide solid beverage | |
CN103169084B (en) | Composition for promoting postpartum recovery and preparation method thereof | |
CN111771970A (en) | Composition beneficial to nourishing and protecting stomach and preparation method thereof | |
CN101836679A (en) | High efficiency weight reducing milk tea and manufacture method thereof | |
CN101856090B (en) | Method for preparing nutritious food particles with infant digesting and appetizing factors | |
CN105795279A (en) | Food beverage formula for human nutrition dietetic invigoration | |
CN103392982B (en) | Detoxifying milk powder | |
CN103622090A (en) | Novel paste capable of strengthening kidney and enhancing physical strength | |
CN107821619A (en) | A kind of production technology of high-quality Tofu pudding | |
CN107302999A (en) | Tuber of dwarf lilyturf health care nutrition powder | |
CN113208079A (en) | A lyophilized chicken soup with health promoting effect and its preparation method | |
CN106376797A (en) | Hericium erinaceus-malt composite vegetable beverage and preparation process thereof | |
CN113973921B (en) | Goat milk powder beneficial to rapid protein absorption and preparation method thereof | |
CN105661286A (en) | Rice porridge suitable for eating in confinement and preparation method of rice porridge | |
CN107212345A (en) | A kind of instant chicken soup product and preparation method thereof | |
CN109567180A (en) | It is a kind of to can be used for women warp, pregnant, production, the nutriment of newborn phase and preparation method thereof | |
CN108576234A (en) | Improve the food and preparation method thereof of cesarean lactation amount | |
CN105995989A (en) | Food for infantile iron deficiency and preparation method thereof | |
CN106387423A (en) | Piglet feed for weaning piglets |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171013 |
|
RJ01 | Rejection of invention patent application after publication |